Fundraising September 15, 2024 – October 1, 2024 About fundraising
1

Insulinsensitizer: Der Insulinresistenz entgegen

Year:
2002
Language:
german
File:
PDF, 361 KB
german, 2002
2

Adipositas — Behandlung beim Typ-2-Diabetiker: Erschwertes Abnehmen

Year:
2002
Language:
german
File:
PDF, 179 KB
german, 2002
4

Nanogramm-Analytik mit Radioimmunoassay Prinzip und Durchführung

Year:
1975
Language:
german
File:
PDF, 1.29 MB
german, 1975
14

Editorial: Pharmazie in unserer Zeit 3/2002

Year:
2002
Language:
german
File:
PDF, 55 KB
german, 2002
15

Gentherapie — die Methode der Zukunft zur kausalen Therapie des Diabetes?

Year:
2002
Language:
german
File:
PDF, 150 KB
german, 2002
16

Pharmakoökonomie: Wieviel kostet der Typ-2-Diabetes?

Year:
2002
Language:
german
File:
PDF, 107 KB
german, 2002
17

Beginn der klinischen Prüfungen des Wirkstoffes Icatibant

Year:
2002
Language:
german
File:
PDF, 112 KB
german, 2002
25

The FK506 binding protein 13 kDa (FKBP13) interacts with the C-chain of complement C1q

Year:
2004
Language:
english
File:
PDF, 648 KB
english, 2004
26

Ultrazentrifugation

Year:
1978
Language:
german
File:
PDF, 2.55 MB
german, 1978
27

Aktuelle Aspekte bei der Anwendung von Clonidin

Year:
1983
Language:
german
File:
PDF, 450 KB
german, 1983
28

Local formation of angiotensin peptides with paracrine activity by adipocytes

Year:
2009
Language:
english
File:
PDF, 467 KB
english, 2009
36

Antidiabetic Effects of a Standardized Egyptian Rice Bran Extract

Year:
2012
Language:
english
File:
PDF, 349 KB
english, 2012
47

Evidence for cholecystokinin receptor subtype in endocrine pancreas

Year:
1994
Language:
english
File:
PDF, 737 KB
english, 1994